$EYEN Long Idea (Insiders Buy)Insiders bought huge amount at $4. Low risk High Reward play. Stop set at the 3.75. Targets are 5 and above.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.7313 USD
−27.26 M USD
3.79 K USD
77.72 M
About Eyenovia, Inc.
Sector
CEO
Michael M. Rowe
Headquarters
New York
Website
Founded
2014
FIGI
BBG00JKZRCH4
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
EYEN dip right to its support zone! hmm😛EYEN in the extreme oversold area on the RSI
great risk reward if we entry around these areas with a tight stop loss.
It can still a risky swing because sometimes penny stocks can see big gap downs before market even opens. so be cautious.
stop loss 3.75, price target 5-5.2
before EYEN 100% spikelooking to enter at 5.08 +/- price change and prepare for the jump back to 10 price tag. This company has huge market potential in asia (china and korea) as they focus on develop treatment solution for short-sighted folks.
EYEN: Higher price rejection after spike upHigher price rejection after spike up
May try to fill the gap
If confirmed
PT1 = 4,76
PT2 = 3,69
Eyenovia and Arctic Vision Announce Exclusive CollaborationEyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea
Eyenovia Eligible to Receive up to a Total of $45.75 million in Upfront Payments and Development and Commercialization Milestones a
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EYEN is 0.0924 USD — it has decreased by −22.48% in the past 24 hours. Watch Eyenovia, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eyenovia, Inc. stocks are traded under the ticker EYEN.
EYEN stock has fallen by −80.09% compared to the previous week, the month change is a −84.07% fall, over the last year Eyenovia, Inc. has showed a −93.16% decrease.
We've gathered analysts' opinions on Eyenovia, Inc. future price: according to them, EYEN price has a max estimate of 4.50 USD and a min estimate of 2.00 USD. Watch EYEN chart and read a more detailed Eyenovia, Inc. stock forecast: see what analysts think of Eyenovia, Inc. and suggest that you do with its stocks.
EYEN reached its all-time high on Jan 25, 2018 with the price of 10.7400 USD, and its all-time low was 0.0862 USD and was reached on Nov 15, 2024. View more price dynamics on EYEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EYEN stock is 43.27% volatile and has beta coefficient of 2.66. Track Eyenovia, Inc. stock price on the chart and check out the list of the most volatile stocks — is Eyenovia, Inc. there?
Today Eyenovia, Inc. has the market capitalization of 7.99 M, it has decreased by −70.75% over the last week.
Yes, you can track Eyenovia, Inc. financials in yearly and quarterly reports right on TradingView.
Eyenovia, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
EYEN earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.13 USD resulting in a 12.40% surprise. The estimated earnings for the next quarter are −0.08 USD per share. See more details about Eyenovia, Inc. earnings.
Eyenovia, Inc. revenue for the last quarter amounts to 1.63 K USD, despite the estimated figure of 153.10 K USD. In the next quarter, revenue is expected to reach 834.67 K USD.
EYEN net income for the last quarter is −7.89 M USD, while the quarter before that showed −11.05 M USD of net income which accounts for 28.64% change. Track more Eyenovia, Inc. financial stats to get the full picture.
No, EYEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 57.00 employees. See our rating of the largest employees — is Eyenovia, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eyenovia, Inc. EBITDA is −30.70 M USD, and current EBITDA margin is −650.20 K%. See more stats in Eyenovia, Inc. financial statements.
Like other stocks, EYEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eyenovia, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eyenovia, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eyenovia, Inc. stock shows the strong sell signal. See more of Eyenovia, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.